Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
Date:12/10/2008

ur Phase II trial testing bavituximab and docetaxel in advanced breast cancer patients. Our anti-viral program received global attention with a publication in the leading journal Nature Medicine highlighting the broad anti-viral potential of bavituximab and other anti-PS antibodies, and we were also awarded a broad U.S. patent covering anti-viral applications of antibodies that directly target PS. These developments, following a major government contract award last quarter to study bavituximab in viral hemorrhagic fever infections, have established our PS-targeting anti-viral platform as an approach that could represent a completely new class of drugs for the treatment of life-threatening viral infections. We look forward to reporting continued progress in our anti-PS programs in the coming months, as well as providing an update on progress in our Cotara(R) clinical program."

Mr. King continued, "Our Avid manufacturing subsidiary continued to expand its client base during the quarter and increased its manufacturing capacity with the addition of an innovative single-use bioreactor system, which should allow Avid to meet the growing demand for its cell culture production services using state-of-the-art, cost-effective technology. Avid revenues recorded this quarter were lower than last year's as a result of the timing of shipments of finished product to customers, but based on product now being readied for shipping and our backlog of orders in hand, we expect robust revenue growth from Avid over the remainder of the fiscal year, with revenues in the third quarter of FY 2009 estimated at upwards of $5 million."

Mr. King concluded, "Despite the turmoil in the global financial markets, we have never been more optimistic about the potential of our lead drug candidates. The encouraging progress in our clinical programs to date and increasing scientific recognition of the promise of our innovative technology have already
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
5. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
6. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
7. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
8. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
9. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
10. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference
11. Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 “ Radaris ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... data they need on a person. , According to Psychology ... even goes on to explain that curiosity is a part ...
(Date:6/2/2015)... MedPro Healthcare Staffing, the leading provider of temporary ... the worldwide release of the MedPro Top Jobs app, ... find best jobs that fit their needs. , According ... 10 job seekers report they’re likely to use a ... Top Jobs app gives its users 24/7 mobile access ...
(Date:6/2/2015)... ZOOM+, the Portland-based health innovator of on-demand ... today the opening of its on-demand ZOOM+Smile studio. ZOOM+Smile ... complete dental exam, cleaning and whitening in 57 minutes, ... ZOOM+ services, ZOOM+Smile can be scheduled by mobile phone ... be as inviting as your favorite coffee shop?” said ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 DiaTech ... drug response profiling test to help oncologists provide ... College of American Pathologists (CAP) for its laboratories ... CAP certification is equivalent to the ‘Good Housekeeping’ ... and chief executive officer for DiaTech. “It’s a ...
(Date:6/2/2015)... New Haven, CT (PRWEB) June 02, 2015 ... the Year by Platform to Employment , a Connecticut ... prepare long-term unemployed workers and place them at appropriate companies. ... WorkPlace in partnership with the Connecticut Department of Labor. ... and a participant in the program, is being recognized for ...
Breaking Medicine News(10 mins):Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:CRN Named Company Partner of the Year by CT Employment Program 2
... of disease are still small , , TUESDAY, Nov. 4 (HealthDay ... higher risk of developing a rare form of lymphoma, new ... cancer is still tiny, amounting to about 0.1 to 0.3 ... Dutch authors of a study published in the Nov. 5 ...
... Clinic Administrator Sentenced to 70 Months for $11 ... physician Ronald,Harris, 58, was sentenced today to 84 ... 40, was sentenced today to 70 months in,prison ... large scale,HIV infusion fraud schemes, Acting Assistant Attorney ...
... Healthcare Realty,Trust Incorporated (NYSE: HR ) ... quarter ended September 30, 2008. This dividend, in ... December 3, 2008 to shareholders,of record on November ... real estate investment trust that,integrates owning, managing and ...
... United American,Healthcare Corporation has nominated Bruce R. Galloway for ... Meeting of Shareholders scheduled,for Friday, November 7, 2008., ... shares of United,American Healthcare,s common stock, Lloyd I. Miller ... The proposal for the election of directors,is more fully ...
... of Virginia Health System report that a daily single oral ... the arms and legs of healthy older adults without serious ... in reducing age-related frailty. , Published in the November 4, ... study showed that levels of growth hormone (GH) and of ...
... now have many more treatment options than in the ... derived by modifying substances found in humans or animals, ... the symptoms. The cost of biologic DMARDs is a ... 100 times more than a year,s supply of older, ...
Cached Medicine News:Health News:Silicone Breast Implants Might Raise Risk of Rare Lymphoma 2Health News:Miami Physician Sentenced to 84 Months in Prison for $26.2 Million Medicare Fraud 2Health News:Miami Physician Sentenced to 84 Months in Prison for $26.2 Million Medicare Fraud 3Health News:Healthcare Realty Trust Announces Third Quarter Dividend 2Health News:Medicaid policies vary widely for rheumatoid arthritis drugs 2
(Date:6/2/2015)... , June 2, 2015   PDI ... solutions, today announced a series of corporate commitments ... strategies to reduce the threat of antimicrobial-resistant microorganisms ... US Centers for Disease Control and Prevention (CDC) ... Strategy to Combat Antibiotic-Resistant Bacteria. Along ...
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has ... Equipment - Global Strategic Business Report" report to their ... the US, Canada , Japan ... , Latin America , and Rest ... period 2014 through 2020. Also, a seven-year historic analysis is ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ... Closures - Global Strategic Business Report" report to their ... the US, Canada , Japan ... , Latin America , and Rest ... for Surgical Incision Closures in US$ Million by the following ...
Breaking Medicine Technology:PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3Surgical Incision Closures - Global Strategic Business Report 2015 2
Three 2 mm prongs with 0.1 mm angled tips. 20 gauge (.89 mm) diameter shaft. Lightweight Wilson style squeeze handle with dull finish. Most popular size or model....
Straight shafts with 1 x 2 teeth. Flat handle with polished finish....
Straight shafts with 45 degrees, 0.12 mm, 2 x 3 teeth and tying platform. Serrated handle with polished finish....
Colibri style 0.1 mm Pierse tips. Flat smooth handle with dull finish....
Medicine Products: